Objection to Genetically Modified Maize MIR 162 Authorization

by name voted on 03.10.2023

Summary

The European Parliament objects to the renewal of authorization for genetically modified maize MIR 162, citing scientific concerns and undemocratic decision-making.

9 03.10.2023

Other

health

environment

agri-foodstuffs

public administration

agriculture, forestry and fisheries

Key points

The European Parliament opposes the renewal of authorization for products containing genetically modified maize MIR 162.
There are concerns that current toxicity assessments are inaccurate because they use isolated proteins instead of whole plant tissue.
Potential health risks include possible side effects on the immune system and increased allergenicity.
Evidence suggests that the maize may experience reduced fertility, a problem that could be worsened by climate change factors like drought.

Vote

PPE

S&D

Renew

Verts/ALE

ECR

ID

NI

The Left

Total

Documents (PDFs)

MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified maize MIR162 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council and amending Commission Implementing Decisions (EU) 2016/1685, 2019/1305 and 2019/2087 as regards the reference material Genetically modified maize MIR 162

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.